UCB - ДОЛГ





ДОЛГ Изменить Дата
Alcon AG USD 5.25B 4.74B 2026-03
Almirall EUR 342.86M 61.94M 2025-12
Amarin USD 0 0 2025-03
argenx SE USD 47.16M 4.01M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GRIFOLS EUR 9.57B 746.56M 2025-12
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
Merck EUR 11.95B 152M 2025-12
Novartis USD 47B 11.62B 2026-03
Orion EUR 305.4M 15.8M 2025-12
Recordati EUR 2.47B 37.48M 2025-12
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
UCB EUR 3.03B 12M 2024-12
Unibail Rodamco EUR 27.56B 297.9M 2024-12